Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.
Michael D. Berquist, Lisa E Baker
Behavioural Pharmacology August 2017 DOI: 10.1097/fbp.0000000000000310 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical drug discrimination study Peer reviewed |
|---|---|
| Population | Male Sprague-Dawley rats |
| Interventions | MDPV D-amphetamine (+)-methamphetamine (-)-cocaine (+)-lysergic acid diethylamide (+)-fenfluramine 3 4-methylenedioxymethamphetamine 4-methylmethcathinone |
| Dose | 0.3 mg/kg MDPV |
| Duration | Approximately 35 training sessions before substitution tests |
| Key points | MDPV's discriminative stimulus cue was fully substituted by the predominantly dopaminergic drugs D-amphetamine, (+)-methamphetamine, and (-)-cocaine, but not by MDMA, 4-methylmethcathinone, or LSD. The serotonin releaser (+)-fenfluramine fully substituted in half the subjects yet completely suppressed responding in the rest. The authors conclude the MDPV cue resembles cues from drugs with predominantly dopamine-increasing effects, and perhaps serotonin-releasing effects in individual subjects. |
Abstract
Recreational use of 3,4-methylenedioxypyrovalerone (MDPV) in the early 2000s prompted numerous scientific investigations of its behavioral and neurochemical effects. The purpose of this study was to further characterize the interoceptive stimulus effects of MDPV using a validated in-vivo drug-detection assay. Male Sprague-Dawley rats were trained to discriminate 0.3 mg/kg MDPV from saline under a fixed ratio 20 (FR 20) schedule of food reinforcement. After stimulus control was established with MDPV (∼35 training sessions), substitution tests were commenced with drugs from several chemical classes, including drugs with predominantly dopaminergic actions [MDPV, D-amphetamine, (+)-methamphetamine, (-)-cocaine], drugs with predominantly serotonergic actions [(+)-lysergic acid diethylamide, (+)-fenfluramine], and drugs with both serotonergic and dopaminergic actions (3,4-methylenedioxymethamphetamine, 4-methylmethcathinone). Full substitution for the 0.3 mg/kg MDPV cue was observed with D-amphetamine, (+)-methamphetamine, and (-)-cocaine. Surprisingly, the 5-HT releaser (+)-fenfluramine fully substituted in half the subjects, but completely suppressed responding in the remaining subjects. 3,4-Methylenedioxymethamphetamine, 4-methylmethcathinone, and (+)-lysergic acid diethylamide failed to fully substitute for MDPV. These results indicate that the MDPV cue is similar to cues produced by drugs with predominantly dopamine-increasing effects and perhaps serotonin-releasing effects among individual subjects. Given these findings, further research is warranted to directly assess the contributions of dopamine and serotonin receptor isoforms to the discriminative stimulus functions of MDPV.
Citations in the library
Cites 3
- The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology December 14, 2011
- Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology January 2007
- Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats. Pharmacology, Biochemistry, and Behavior February 1996